We are proud to announce our collaboration with the University of Bristol, Brainstrust and Cancer Research UK to develop an affordable, point of care test for earlier detection of brain tumours.
The cross disciplinary research project brings together medical practitioners along with experts in population health, nanoparticle engineering and detection, as well as computational modelling.
A statement from our CEO:
“As a diagnostic company we are passionate about creating technology that can improve people’s lives, we see this project as a natural extension of the work we are currently doing in infectious disease”
Read the full press release here: